See more : Arovella Therapeutics Limited (ALA.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Feishang Anthracite Resources Limited (FSHRF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Feishang Anthracite Resources Limited, a leading company in the Coal industry within the Energy sector.
- Canadian Metals Inc. (CME.CN) Income Statement Analysis – Financial Results
- Jointown Pharmaceutical Group Co., Ltd (600998.SS) Income Statement Analysis – Financial Results
- Total Access Communication Public Company Limited (DTAC-R.BK) Income Statement Analysis – Financial Results
- Asian Phytoceuticals Public Company Limited (APCO.BK) Income Statement Analysis – Financial Results
- BioNeutra International, Ltd. (BIMO) Income Statement Analysis – Financial Results
Feishang Anthracite Resources Limited (FSHRF)
About Feishang Anthracite Resources Limited
Feishang Anthracite Resources Limited, an investment holding company, engages in the extraction, sale, and trade of anthracite coal in the People's Republic of China. It engages in the acquisition, construction, development, and operation of anthracite coal mines. The company operates four coal mines in Guizhou province. It is also involved in the coal washing activities. The company was formerly known as Wealthy Year Limited. Feishang Anthracite Resources Limited was incorporated in 2010 and is based in Sheung Wan, Hong Kong. Feishang Anthracite Resources Limited operates as a subsidiary of Feishang Industrial Group Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 990.79M | 1.60B | 1.12B | 1.01B | 1.15B | 1.23B | 1.02B | 557.86M | 239.89M | 363.37M | 178.50M | 141.94M | 105.21M |
| Cost of Revenue | 758.33M | 942.67M | 722.22M | 715.64M | 832.58M | 577.86M | 492.50M | 380.64M | 237.74M | 276.15M | 108.24M | 95.89M | 74.29M |
| Gross Profit | 232.45M | 660.52M | 398.79M | 297.44M | 317.15M | 656.29M | 530.45M | 177.22M | 2.15M | 87.22M | 70.26M | 46.05M | 30.92M |
| Gross Profit Ratio | 23.46% | 41.20% | 35.57% | 29.36% | 27.58% | 53.18% | 51.85% | 31.77% | 0.90% | 24.00% | 39.36% | 32.44% | 29.39% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 165.10M | 160.60M | 133.92M | 139.88M | 135.33M | 123.37M | 106.88M | 87.24M | 78.17M | 115.00M | 142.06M | 77.33M | 49.43M |
| Selling & Marketing | 99.74M | 118.48M | 106.48M | 106.54M | 116.42M | 48.22M | 28.24M | 21.80M | 8.96M | 8.77M | 6.11M | 3.69M | 2.93M |
| SG&A | 264.85M | 279.08M | 240.40M | 246.42M | 251.75M | 171.59M | 135.11M | 109.04M | 87.13M | 123.78M | 148.17M | 81.03M | 52.36M |
| Other Expenses | -32.39M | 95.36M | 36.82M | 20.71M | 29.46M | -1.36M | -2.64M | -2.81M | -616.00K | -1.23M | 985.00K | -540.00K | -341.00K |
| Operating Expenses | 232.45M | 374.44M | 277.22M | 267.13M | 281.21M | 184.72M | 123.50M | 133.83M | 91.88M | 131.05M | 154.90M | 83.29M | 54.45M |
| Cost & Expenses | 990.79M | 1.32B | 999.44M | 982.77M | 1.11B | 762.58M | 616.00M | 514.47M | 329.62M | 407.19M | 263.14M | 179.18M | 128.74M |
| Interest Income | 1.48M | 575.00K | 1.91M | 2.75M | 775.00K | 373.00K | 3.47M | 3.99M | 2.46M | 2.72M | 1.10M | 1.05M | 564.00K |
| Interest Expense | 140.99M | 151.38M | 160.55M | 163.17M | 90.78M | 91.69M | 72.87M | 70.55M | 116.89M | 132.46M | 104.79M | 43.77M | 30.82M |
| Depreciation & Amortization | 235.66M | 326.23M | 253.74M | 268.46M | 342.80M | 193.39M | 211.53M | 158.40M | 130.80M | 111.94M | 25.14M | 17.81M | 13.04M |
| EBITDA | -111.96M | 609.69M | 371.77M | 39.68M | 375.28M | 651.81M | 609.15M | 48.86M | -344.66M | -588.00K | -252.42M | -19.04M | -11.29M |
| EBITDA Ratio | -11.30% | 38.20% | 33.39% | 29.55% | 32.97% | 53.78% | 60.50% | 36.27% | 17.19% | 16.15% | -37.62% | -13.42% | -10.21% |
| Operating Income | -81.94M | 286.20M | 121.44M | 30.87M | 31.13M | 455.40M | 398.66M | -111.38M | -474.57M | -109.43M | -268.34M | -36.60M | -22.99M |
| Operating Income Ratio | -8.27% | 17.85% | 10.83% | 3.05% | 2.71% | 36.90% | 38.97% | -19.96% | -197.83% | -30.11% | -150.33% | -25.79% | -21.85% |
| Total Other Income/Expenses | -406.67M | -154.01M | -163.95M | -162.81M | -89.43M | -86.70M | -60.93M | -68.72M | -117.78M | -144.42M | -114.02M | -45.03M | -32.17M |
| Income Before Tax | -488.61M | 132.08M | -42.51M | -387.85M | -58.30M | 368.56M | 337.74M | -180.10M | -592.35M | -253.93M | -382.35M | -82.27M | -55.15M |
| Income Before Tax Ratio | -49.32% | 8.24% | -3.79% | -38.28% | -5.07% | 29.86% | 33.02% | -32.28% | -246.93% | -69.88% | -214.20% | -57.96% | -52.42% |
| Income Tax Expense | 30.46M | 58.16M | 50.38M | -40.92M | 17.54M | 117.28M | 117.18M | 20.74M | -86.39M | -27.10M | -47.82M | -15.21M | 9.75M |
| Net Income | -493.42M | 73.92M | -92.89M | -346.93M | -75.84M | 200.63M | 182.54M | -212.74M | -514.98M | -223.60M | -334.12M | -75.31M | -64.17M |
| Net Income Ratio | -49.80% | 4.61% | -8.29% | -34.25% | -6.60% | 16.26% | 17.84% | -38.14% | -214.68% | -61.54% | -187.18% | -53.06% | -60.99% |
| EPS | -0.71 | 0.06 | -0.07 | -0.25 | -0.06 | 0.15 | 0.13 | -0.16 | -0.37 | -0.18 | -0.28 | -0.07 | -0.05 |
| EPS Diluted | -0.71 | 0.06 | -0.07 | -0.25 | -0.06 | 0.15 | 0.13 | -0.15 | -0.37 | -0.18 | -0.27 | -0.06 | -0.05 |
| Weighted Avg Shares Out | 691.10M | 1.38B | 1.38B | 1.38B | 1.38B | 1.38B | 1.38B | 1.37B | 1.38B | 1.23B | 1.20B | 1.20B | 1.25B |
| Weighted Avg Shares Out (Dil) | 690.27M | 1.38B | 1.38B | 1.38B | 1.38B | 1.38B | 1.38B | 1.38B | 1.38B | 1.25B | 1.25B | 1.25B | 1.25B |
Source: https://incomestatements.info
Category: Stock Reports